Wordt geladen...
Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
BACKGROUND: Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to explore the associations between enhancer of zeste homolog 2 (EZH2) and patient survival in various cancers. METHODS: Relevant literature was retrieved from PubMed and Web of Science database...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4431777/ https://ncbi.nlm.nih.gov/pubmed/25974088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125480 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|